Immunomedics (IMMU) Stock: Heads Up On Regulatory Update
Immunomedics, Inc. (NASDAQ: IMMU) is having a relatively strong start to the trading session this morning, and for good reason. The company announced that the FDA has accepted its Biologics License Agreement, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about: The acceptance of the Biologics License … Read more